Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has signed a Memorandum of Understanding (MoU) with Mission for Essential Drugs and Supplies (MEDS) to further expand the impact of Boehringer Ingelheim’s ‘Access to Healthcare’ program. The partnership aims to improve access to affordable, life-saving medication for patients living with type 2 diabetes and hypertension in Kenya… Read More »Boehringer Ingelheim And Mission For Essential Drugs And Supplies Partner To Further Enhance Access To Non-communicable Diseases In Kenya
